ORYZON recibe la “Decisión de concesión” para dos importantes patentes de vafidemstat en Japón
Para el tratamiento del Trastorno Límite de la Personalidad (TLP) y Trastorno por Déficit de Atención e Hiperactividad (TDAH) Oryzon
Read MorePara el tratamiento del Trastorno Límite de la Personalidad (TLP) y Trastorno por Déficit de Atención e Hiperactividad (TDAH) Oryzon
Read MoreMuchos de estos síntomas son notables y tienen un impacto directo en la vida de quien lo padece El Trastorno
Read MoreCookie | Duración | Descripción |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |